Australia Autoimmune Haemolytic Anemia (AIHA) Market Analysis

$3,500.00$7,500.00

  • Type: Rare Disease Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4077

  • Format: PPT, PDF

Australian Autoimmune Haemolytic Anaemia (AIHA) Therapeutics Market: Segmented by Diagnosis, Treatment, Distribution Channels, and End Users – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028F)

Clear
SKU: 4077 Categories: ,

Report Overview

The Australian Autoimmune Haemolytic Anaemia (AIHA) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Autoimmune Haemolytic Anaemia (AIHA) is an autoimmune disorder characterised by the premature destruction of healthy red blood cells (RBCs) by auto-antibodies. It is a common disorder directed against self RBCs which can be idiopathic (primary) or secondary. In w-AIHA, the autoantibodies react optimally with the RBCs at 37C. Normally, red blood cells live in the body for 100 to 120 days. However, in severe cases of AIHA, the cells may remain only for a few days. In children, it is a rare condition that is usually temporary. In some adults, however, AIHA can be a long-term condition that returns frequently. AIHA can develop rapidly or over time. A decreased number of red blood cells (anemia) may cause fatigue, weakness, a pale skin color (pallor), dizziness, palpitations, and shortness of breath (dyspnea).
Recently in June, 2020, 5 cases of AIHA were reported in Australia. Serologically, cases are divided into warm, cold (cold haemagglutinin disease and paroxysmal cold haemoglobinuria) or mixed AIHA.

Market Drivers

The market for Autoimmune Haemolytic Anaemia (AIHA) is primarily driven by a rise in the usage of medications for patients with Autoimmune Haemolytic Anaemia, such as corticosteroids. Because of the fast growing geriatric population, the prevalence of AIHA is increasing. Because the older population has a lower immune system, they are more susceptible to diseases, which fuels market growth. The steady increase in the use of immunoglobulin for treatment of off-label indications is expected to drive the market during the forecast period. Technological improvements in the production and purification methods of intravenous immunoglobulins (IVIG) have made these safer and free from protein, viral, or any other contaminants. This has increased clinician preference for usage of IVIG. This in turn, boosts the market growth during the forecast period.
When compared to materials and methods utilised in the production of traditional pharmaceutical goods, plasma collection and manufacturing methods are expensive. Furthermore, because Intravenous Immunoglobulin (IVIG) products are obtained from blood, more sophisticated collection, purification, and storage processes are necessary.

1. Australian AIHA Therapeutics Market Overview……………………………………
A. Market Size
2. Market Growth Drivers…………………………..………………………………………
A. Increase in Disease Burden of Autoimmune Haemolytic Anaemia (AIHA)
B. Increase in Geriatric Population Fosters the Market Growth
C. Rise in demand for the Development of Combination Therapies
3. Major Types of AIHA…………………………………………………………………….
A. Primary AIHA
B. Secondary AIHA
C. Warm AIHA
D. Cold AIHA
E. Mixed AIHA
4. AIHA Therapeutics Market Segmentation…………………………………………………
A. By Diagnosis
I. Coomb’s Test
II. Bilirubin Test
III. Haptoglobin Test
IV. Reticulocyte Count
V. Peripheral Smear
VI. Cold Agglutinin Titre
B. By Treatment
I. Corticosteroids
II. Intravenous Immunoglobulins (IVIG)
III. Monoclonal Antibodies
IV. Immunosuppressants
V. Blood Transfusion
VI. Splenectomy (Surgery)
C. By Distribution Channels
I. Retail Pharmacies
II. Hospital Pharmacies
III. Online Pharmacies
D. By End Users
I. Hospitals and Clinics
II. Homecare
III. Speciality Centres
IV. Others
5. AIHA Major Drugs Market Share………………………………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Pfizer Company overview, Product & Services, Strategies & Financials
B. Roche Company overview, Product & Services, Strategies & Financials
C. Kezar Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………..
A. New Trends and Development of AIHA therapeutics market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Diagnosis:

Based on diagnosis, the Australian AIHA market is segregated into coomb’s test, bilirubin test, haptoglobin test, reticulocyte count, peripheral smear, and cold agglutinin titre. A low red blood cell count, low haemoglobin and haematocrit levels are signs of anaemia; thus, physicians advise AIHA patients to diagnose by these tests to confirm the disease.
The following sequence allows the diagnosis of WAHA:
1) Detection of anemia with increased reticulocyte counts,
2) Determination that the anemia is caused by hemolysis, based on elevated bilirubin and LDH and low haptoglobin,
3) Determination that WAHA is the cause of Hemolytic Anemia with a Coombs test and
4) Possible investigation for a secondary cause of WAHA.

By Treatment:

On the basis of treatment, the AIHA Therapeutics market can be divided into medication, blood transfusion, splenectomy (surgery) and others. The medication is further segmented into corticosteroids such as hydrocortisone or prednisone, intravenous immunoglobulins (IVIG), monoclonal antibodies such as rituximab and immunosupressants like azathioprine and cyclophosphamide. The corticosteroids segment is anticipated to dominate the AIHA market during the forecast period due to an increase in the usage of corticosteroids for the treatment of autoimmune haemolytic anaemia.

By Distribution Channels:

In terms of distribution channels, the AIHA Therapeutics market has been bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is likely to account for a major share of the autoimmune haemolytic anaemia market during the forecast period due to a large number of AIHA patients treated in hospitals.

By End Users:

As per the end user, the AIHA Therapeutics market has been segmented into hospitals, homecare, specialty centres and others. The hospitals segment commands the largest market share in terms of value during the forecast period.

Top Major Players

The major key players operating in Australian Autoimmune Haemolytic Anaemia (AIHA) Therapeutic market are Kezar Life Sciences Inc., Alexion Pharmaceuticals, and Alphapharm Pty Ltd., LEO Pharma Pty Ltd., Roche Products Pty Ltd., Pfizer Australia Pty Ltd among others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements